Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 62,800 ATNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 62,800 | n/a |
| Dec 10, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Disposition to Issuer | 8,000 | n/a |
| Jun 20, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Grant/Award | 10,450 | n/a |
| Apr 2, 2025 | Actinium Pharmaceuticals, Inc. (ATNM) | Disposition to Issuer | 2,500 | n/a |
| Jun 20, 2024 | Adverum Biotechnologies, Inc. (ADVM) | Grant/Award | 10,520 | n/a |
| Dec 29, 2023 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 70,311 | n/a |
| Nov 7, 2023 | Adverum Biotechnologies, Inc. (ADVM) | Grant/Award | 80,000 | n/a |
| Jul 1, 2022 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 72,156 | n/a |
| Sep 3, 2021 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 18,351 | n/a |
| Aug 14, 2020 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 8,333 | n/a |